NSG 554 EXAM 3 - NURSE PRACTITIONERS IN PRIMARY
CARE I | 65 ACTUAL QUESTIONS AND ANSWERS + EXPERT
RATIONALES | 2026/27 UPDATES | 100% CORRECT
240 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NSG 554 EXAM 3 - NURSE PRACTITIONERS IN PRIMARY CARE I | 65 ACTUAL QUESTIONS AND
ANSWERS + EXPERT RATIONALES | 2026/27 UPDATES | 100% CORRECT. It contains 240 carefully selected
questions that reflect the most current exam content and testing strategies. Each question is accompanied by a
correct answer and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical
reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 240 Questions
Foundations - Application - NSG 554 3 Nurse Practitioners IN Primary CARE I 65 Actual AND Expert
Rationales 2026/27 Updates 100 Correct Nursing Primary CARE Nurse Practitioner Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
NSG 554 3 Nurse 1-40 Diabetes, Hypertension, Chronic, Disease, Medication
Practitioners IN Primary
CARE I 65 Actual AND Expert
Rationales 2026/27 Updates
100 Correct Nursing Primary
CARE Nurse Practitioner
Graduate
Chronic 41-80 Appropriate, Diabetes, Kidney, Disease, According
Diabetes 81-120 Chronic, Therapy, Appropriate, Hypertension, Guidelines
Disease 121-160 Appropriate, Chronic, Guidelines, Diabetes, Kidney
Kidney 161-200 Appropriate, Chronic, Diabetes, Finding, Acute
Hypertension 201-240 Appropriate, Presents, Chronic, Kidney, Disease
TOTAL 240 All questions include answers and detailed rationales
,Section A - NSG 554 3 Nurse Practitioners IN Primary
CARE I 65 Actual AND Expert Rationales 2026/27 Updates
100 Correct Nursing Primary CARE Nurse Practitioner
Graduate
Q1.
A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 42 mL/min) is on
metformin and lisinopril. Recent labs show HbA1c 8.1%, blood pressure 138/86 mmHg,
and urine albumin-to-creatinine ratio 450 mg/g. Which medication addition is most aligned
with current guidelines to reduce cardiovascular and renal risk?
A. Empagliflozin B. Glipizide
C. Sitagliptin D. Insulin glargine
Correct: A - Empagliflozin
Rationale:SGLT2 inhibitors like empagliflozin are recommended in patients with T2DM, CKD,
and albuminuria to slow CKD progression and reduce cardiovascular risk. Glipizide and
sitagliptin lack these benefits. Insulin glargine is appropriate for glucose control but does not
confer the same renal/cardiovascular protection.
Q2.
A 34-year-old patient with asthma and allergic rhinitis reports worsening nocturnal cough
despite daily inhaled corticosteroid (ICS) and as-needed albuterol. Which intervention is
most appropriate to recommend before escalating controller therapy?
A. Add a leukotriene receptor antagonist B. Switch to a long-acting beta-agonist
(LTRA) (LABA)/ICS combination
C. Reassess inhaler technique and D. Prescribe a short course of oral
adherence corticosteroids
Correct: C - Reassess inhaler technique and adherence
Rationale:Guidelines emphasize assessing adherence and inhaler technique before stepping
up therapy, as poor technique is a common cause of uncontrolled symptoms. Adding LTRA or
LABA/ICS is premature if adherence/technique issues exist. Oral corticosteroids are reserved
for acute exacerbations, not chronic poor control.
Q3.
A 58-year-old patient with a 30-pack-year smoking history and a persistent cough
undergoes spirometry showing FEV1/FVC 0.62 and FEV1 62% predicted, with
post-bronchodilator no significant change. Which finding would most alter the usual
Page 3
, Section A - NSG 554 3 Nurse Practitioners IN Primary CARE I 65 Actual AND Expert Rationales 2026/27 Updates 100 Correct Nursing Primary
CARE Nurse Practitioner Graduate
management approach for this patient?
A. Positive alpha-1 antitrypsin deficiency B. Elevated blood eosinophil count of 150
testing cells/µL
C. Comorbid osteoporosis D. History of frequent respiratory infections
Correct: A - Positive alpha-1 antitrypsin deficiency testing
Rationale:Positive AAT deficiency testing identifies a specific genotype that can guide
therapy (e.g., augmentation therapy) and prompts family screening. Elevated eosinophils may
guide ICS use but are not a major change in overall management. Osteoporosis and
infections influence treatment choices but are less critical than identifying a specific disease
subtype.
Q4.
A patient with heart failure with reduced ejection fraction (HFrEF) is on a maximally
tolerated dose of an ACE inhibitor, a beta-blocker, and an aldosterone antagonist. Despite
this, symptoms persist. Which medication class has the strongest evidence for additional
mortality benefit when added to this regimen?
A. SGLT2 inhibitor B. Loop diuretic
C. Calcium channel blocker D. Digoxin
Correct: A - SGLT2 inhibitor
Rationale:SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) reduce mortality and heart
failure hospitalizations in HFrEF regardless of diabetes status. Loop diuretics relieve
congestion but do not reduce mortality. Calcium channel blockers are not recommended for
HFrEF. Digoxin improves symptoms but does not reduce mortality.
Q5.
A 45-year-old patient with a history of major depressive disorder is being started on an
SSRI. Which concurrent medication would most warrant a different antidepressant choice
due to a potentially life-threatening interaction?
A. Warfarin B. Tramadol
C. Omeprazole D. Oral contraceptive pill
Correct: B - Tramadol
Rationale:Combining an SSRI with tramadol increases the risk of serotonin syndrome, a
potentially fatal condition. Warfarin and SSRIs increase bleeding risk but are manageable.
Omeprazole may increase SSRI levels via CYP2C19 inhibition but is not life-threatening. Oral
contraceptives have no significant interaction.
Page 4
CARE I | 65 ACTUAL QUESTIONS AND ANSWERS + EXPERT
RATIONALES | 2026/27 UPDATES | 100% CORRECT
240 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NSG 554 EXAM 3 - NURSE PRACTITIONERS IN PRIMARY CARE I | 65 ACTUAL QUESTIONS AND
ANSWERS + EXPERT RATIONALES | 2026/27 UPDATES | 100% CORRECT. It contains 240 carefully selected
questions that reflect the most current exam content and testing strategies. Each question is accompanied by a
correct answer and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical
reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 240 Questions
Foundations - Application - NSG 554 3 Nurse Practitioners IN Primary CARE I 65 Actual AND Expert
Rationales 2026/27 Updates 100 Correct Nursing Primary CARE Nurse Practitioner Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
NSG 554 3 Nurse 1-40 Diabetes, Hypertension, Chronic, Disease, Medication
Practitioners IN Primary
CARE I 65 Actual AND Expert
Rationales 2026/27 Updates
100 Correct Nursing Primary
CARE Nurse Practitioner
Graduate
Chronic 41-80 Appropriate, Diabetes, Kidney, Disease, According
Diabetes 81-120 Chronic, Therapy, Appropriate, Hypertension, Guidelines
Disease 121-160 Appropriate, Chronic, Guidelines, Diabetes, Kidney
Kidney 161-200 Appropriate, Chronic, Diabetes, Finding, Acute
Hypertension 201-240 Appropriate, Presents, Chronic, Kidney, Disease
TOTAL 240 All questions include answers and detailed rationales
,Section A - NSG 554 3 Nurse Practitioners IN Primary
CARE I 65 Actual AND Expert Rationales 2026/27 Updates
100 Correct Nursing Primary CARE Nurse Practitioner
Graduate
Q1.
A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 42 mL/min) is on
metformin and lisinopril. Recent labs show HbA1c 8.1%, blood pressure 138/86 mmHg,
and urine albumin-to-creatinine ratio 450 mg/g. Which medication addition is most aligned
with current guidelines to reduce cardiovascular and renal risk?
A. Empagliflozin B. Glipizide
C. Sitagliptin D. Insulin glargine
Correct: A - Empagliflozin
Rationale:SGLT2 inhibitors like empagliflozin are recommended in patients with T2DM, CKD,
and albuminuria to slow CKD progression and reduce cardiovascular risk. Glipizide and
sitagliptin lack these benefits. Insulin glargine is appropriate for glucose control but does not
confer the same renal/cardiovascular protection.
Q2.
A 34-year-old patient with asthma and allergic rhinitis reports worsening nocturnal cough
despite daily inhaled corticosteroid (ICS) and as-needed albuterol. Which intervention is
most appropriate to recommend before escalating controller therapy?
A. Add a leukotriene receptor antagonist B. Switch to a long-acting beta-agonist
(LTRA) (LABA)/ICS combination
C. Reassess inhaler technique and D. Prescribe a short course of oral
adherence corticosteroids
Correct: C - Reassess inhaler technique and adherence
Rationale:Guidelines emphasize assessing adherence and inhaler technique before stepping
up therapy, as poor technique is a common cause of uncontrolled symptoms. Adding LTRA or
LABA/ICS is premature if adherence/technique issues exist. Oral corticosteroids are reserved
for acute exacerbations, not chronic poor control.
Q3.
A 58-year-old patient with a 30-pack-year smoking history and a persistent cough
undergoes spirometry showing FEV1/FVC 0.62 and FEV1 62% predicted, with
post-bronchodilator no significant change. Which finding would most alter the usual
Page 3
, Section A - NSG 554 3 Nurse Practitioners IN Primary CARE I 65 Actual AND Expert Rationales 2026/27 Updates 100 Correct Nursing Primary
CARE Nurse Practitioner Graduate
management approach for this patient?
A. Positive alpha-1 antitrypsin deficiency B. Elevated blood eosinophil count of 150
testing cells/µL
C. Comorbid osteoporosis D. History of frequent respiratory infections
Correct: A - Positive alpha-1 antitrypsin deficiency testing
Rationale:Positive AAT deficiency testing identifies a specific genotype that can guide
therapy (e.g., augmentation therapy) and prompts family screening. Elevated eosinophils may
guide ICS use but are not a major change in overall management. Osteoporosis and
infections influence treatment choices but are less critical than identifying a specific disease
subtype.
Q4.
A patient with heart failure with reduced ejection fraction (HFrEF) is on a maximally
tolerated dose of an ACE inhibitor, a beta-blocker, and an aldosterone antagonist. Despite
this, symptoms persist. Which medication class has the strongest evidence for additional
mortality benefit when added to this regimen?
A. SGLT2 inhibitor B. Loop diuretic
C. Calcium channel blocker D. Digoxin
Correct: A - SGLT2 inhibitor
Rationale:SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) reduce mortality and heart
failure hospitalizations in HFrEF regardless of diabetes status. Loop diuretics relieve
congestion but do not reduce mortality. Calcium channel blockers are not recommended for
HFrEF. Digoxin improves symptoms but does not reduce mortality.
Q5.
A 45-year-old patient with a history of major depressive disorder is being started on an
SSRI. Which concurrent medication would most warrant a different antidepressant choice
due to a potentially life-threatening interaction?
A. Warfarin B. Tramadol
C. Omeprazole D. Oral contraceptive pill
Correct: B - Tramadol
Rationale:Combining an SSRI with tramadol increases the risk of serotonin syndrome, a
potentially fatal condition. Warfarin and SSRIs increase bleeding risk but are manageable.
Omeprazole may increase SSRI levels via CYP2C19 inhibition but is not life-threatening. Oral
contraceptives have no significant interaction.
Page 4
